Drug profile · INN
halofantrine hydrochloride
HALFAN
halofantrine hydrochloride (HALFAN) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Drug details — halofantrine hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
halofantrine hydrochloride (HALFAN) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Ferriprotoporphyrin IX inhibitor
Primary target: Ferriprotoporphyrin IX
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is halofantrine hydrochloride?
halofantrine hydrochloride (HALFAN) is a ferriprotoporphyrin ix inhibitor. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for halofantrine hydrochloride?
HALFAN is a marketed brand name for halofantrine hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of halofantrine hydrochloride?
halofantrine hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.